FrançaisAre analysts right about Molina Healthcare (MOH)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Molina Healthcare, we replayed every analyst price target of the past 12 months and measured the real outcome: 47% were profitable, average return +9% (163 calls). At 3 months: +0% average return (41% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 24 | 67% | +29% |
| Wells Fargo | 14 | 21% | -10% |
| B of A Securities | 13 | 38% | +7% |
| Jefferies | 11 | 46% | +9% |
| JP Morgan | 11 | 46% | +24% |
Frequently asked questions
Is Molina Healthcare a buy right now?
The analyst consensus on Molina Healthcare (MOH) is "Hold" (3 bullish, 7 bearish calls over 12 months). This is not advice: historically, 47% of their targets on this stock turned out profitable over 1 year.
What is Molina Healthcare's price target?
The median 12-month price target is $221 (+11% vs $199), ranging from $163 to $230 (10 analysts).
Are analysts accurate on Molina Healthcare?
Over 1 year, 47% of analyst targets on Molina Healthcare were profitable, for an average return of +9% (across 163 timestamped calls). This is JPI Invest's accuracy metric.
What is the Molina Healthcare stock forecast?
Analysts target a median of $221 within 12 months, i.e. +11% vs the current price. The most bullish targets $230, the most cautious $163.
What is the Molina Healthcare stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $221, +11%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (47%), and the stock's past trajectory.
Is Molina Healthcare overvalued?
Detailed valuation data for Molina Healthcare is available in the interactive analysis.
📊 See the full interactive analysis of Molina Healthcare →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.